Managing Director Tarek Choufani signs an Agreement with Truffle Capital to set up ‘TNC BioMedTech Fund’. This Fund will be managed by Truffle Capital under the supervision of CAGF. Its focus will be early-stage investment in
Truffle Capital’s BioMedTech deal pipeline.